- Home
- VNDA vs FCT Comparison
VNDA vs FCT Comparison
Compare VNDA & FCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- FCT
- Stock Information
- Founded
- VNDA 2002
- FCT 2004
- Country
- VNDA United States
- FCT United States
- Employees
- VNDA N/A
- FCT N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- FCT Finance Companies
- Sector
- VNDA Health Care
- FCT Finance
- Exchange
- VNDA Nasdaq
- FCT Nasdaq
- Market Cap
- VNDA 249.4M
- FCT 265.0M
- IPO Year
- VNDA 2006
- FCT N/A
- Fundamental
- Price
- VNDA $4.51
- FCT $9.95
- Analyst Decision
- VNDA Strong Buy
- FCT
- Analyst Count
- VNDA 2
- FCT 0
- Target Price
- VNDA $16.50
- FCT N/A
- AVG Volume (30 Days)
- VNDA 422.6K
- FCT 106.8K
- Earning Date
- VNDA 11-05-2025
- FCT 01-01-0001
- Dividend Yield
- VNDA N/A
- FCT 11.29%
- EPS Growth
- VNDA N/A
- FCT N/A
- EPS
- VNDA N/A
- FCT N/A
- Revenue
- VNDA $203,467,000.00
- FCT N/A
- Revenue This Year
- VNDA $15.45
- FCT N/A
- Revenue Next Year
- VNDA $37.82
- FCT N/A
- P/E Ratio
- VNDA N/A
- FCT N/A
- Revenue Growth
- VNDA 11.78
- FCT N/A
- 52 Week Low
- VNDA $3.81
- FCT $9.45
- 52 Week High
- VNDA $5.55
- FCT $10.42
- Technical
- Relative Strength Index (RSI)
- VNDA 46.90
- FCT 36.04
- Support Level
- VNDA $4.54
- FCT $10.05
- Resistance Level
- VNDA $4.64
- FCT $10.15
- Average True Range (ATR)
- VNDA 0.15
- FCT 0.08
- MACD
- VNDA -0.01
- FCT -0.03
- Stochastic Oscillator
- VNDA 8.89
- FCT 14.71
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is a United States-based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, it attempts to preserve capital. The fund invests in a portfolio of senior secured floating-rate corporate loans (Senior Loans) of companies from different industries, such as Insurance, Software, Health Care Providers and Services, Professional Services, Health Care Technology, IT Services, and others.